Displaying 1 - 4 of 4
Active Ingredient MICONAZOLE
Therapeutic Class AZOLES
Indications Vaginal candidiasis
Caution Vaginal burning, irritation, contact dermatitis.
Dose Range One applicator full at night for 7 nights or 1 ovule at night for 3 nights.
Drug Interactions
Pregnancy Pregnant women need a longer duration of
treatment, usually about 7 days, to cle More ...
Breast Feeding
Active Ingredient METRONIDAZOLE | MICONAZOLE
Therapeutic Class ANTIFUNGALS, MISCELLANEOUS
Indications Bacterial Vaginosis, Trichomonal Vaginitis, Vaginal Candidiasis .
Caution Vaginal burning, irritation. Not to be used during pregnancy particularly the first 3 months. Avoid alcohol during and for at least 24-48 hours after treatment.
Dose Range One applicatorful or one ovule at bedtime for 7 nights.
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient MICONAZOLE
Therapeutic Class ANTIFUNGALS TOPICAL
Indications Tinea and candidiasis infections.
Caution Local irritation and sensitivity reactions.
Dose Range Apply sparingly twice daily to affected areas. Apply once daily for tinea versicolor. See BDS supply protocols pg. 6.
Drug Interactions
Pregnancy
Breast Feeding
Active Ingredient BETAMETHASONE | MICONAZOLE
Therapeutic Class ANTI-INFECTIVES & ANTI-INFLAMMATORIES
Indications Mild inflammatory dermatoses with fungal infection.
Caution Apply sparingly over small area. Avoid use on broken skin. See under Betamethasone Valerate.
Dose Range Apply twice daily. See BDS supply protocols pg. 6.
Drug Interactions
Pregnancy
Breast Feeding